Particle
.news
Healthcare
❯
Pharmaceuticals
❯
Alzheimer's Drugs
Donanemab
Kisunla
Clinical Trials
FDA Approval
12 ARTICLES
last year
FDA Delays Approval of Eli Lilly's Alzheimer's Drug Donanemab